Uploaded May 2026 | Updated September 2026, 2 weeks ago
Carolyn Rodriguez, MD, PhD
Associate Dean for Academic Affairs, Stanford School of Medicine
Professor of Psychiatry and Behavioral Sciences
Director, OCD Research Lab
Obsessive-compulsive disorder (OCD) is common, disabling, and severely underdiagnosed. Standard first-line treatments for OCD may not provide sufficient relief of OCD symptoms for all those seeking care; thus, there is an urgent need for alternative treatments. Learn how Dr. Rodriguez’s lab is transforming the landscape of diagnosis and treatment through two groundbreaking approaches—first, by leveraging artificial intelligence to enable earlier, more accurate detection of OCD; and second, by pioneering the use of rapid-acting therapeutics that target specific brain circuits, offering symptom relief within hours rather than weeks.
Part of Stanford Medicine Alumni Day 2026.
Carolyn Rodriguez, MD, PhD
Associate Dean for Academic Affairs, Stanford School of Medicine
Professor of Psychiatry and Behavioral Sciences
Director, OCD Research Lab
Obsessive-compulsive disorder (OCD) is common, disabling, and severely underdiagnosed. Standard first-line treatments for OCD may not provide sufficient relief of OCD symptoms for all those seeking care; thus, there is an urgent need for alternative treatments. Learn how Dr. Rodriguez’s lab is transforming the landscape of diagnosis and treatment through two groundbreaking approaches—first, by leveraging artificial intelligence to enable earlier, more accurate detection of OCD; and second, by pioneering the use of rapid-acting therapeutics that target specific brain circuits, offering symptom relief within hours rather than weeks.
Part of Stanford Medicine Alumni Day 2026.
